When will Rivaroxaban generic availability occur?

Rivaroxaban, also known as Xarelto, is an anticoagulant medication used to prevent blood clots and strokes. As a brand-name drug, Rivaroxaban has exclusive marketing rights, limiting generic competition.

However, generic versions of Rivaroxaban are already available in the United States and other countries.

Can I buy Rivaroxaban generics in the US?

Yes, [1] multiple generics of Rivaroxaban have gained FDA approval and are currently available in the US market. These generics are manufactured by various companies, including Mylan, Teva, and Sandoz, among others.

What is the current patent status of Rivaroxaban?

The patent for Rivaroxaban expired in 2019 in several countries, including Canada and the European Union. In the US, the patent for Rivaroxaban is set to expire in 2024. [2]

Who are the manufacturers of Rivaroxaban generics?

Several companies have received FDA approval for Rivaroxaban generics, including:

- Mylan Laboratories
- Teva Pharmaceutical Industries
- Sandoz (Novartis)
- Apotex Inc.

These generics are available in various strengths, including 10mg, 15mg, and 20mg tablets.

How do I find affordable Rivaroxaban generics?

Patients can access Rivaroxaban generics through various channels, including:

- Online pharmacies
- Retail pharmacies
- Generic manufacturers' websites
- Patient assistance programs

What should I look for when purchasing Rivaroxaban generics?

When purchasing Rivaroxaban generics, patients should ensure that the product is:

- FDA-approved
- Manufactured by a reputable company
- Has a valid NDC (National Drug Code)
- Has a clear expiration date

By considering these factors, patients can confidently obtain affordable Rivaroxaban generics.

How long does exclusivity last for brand-name Rivaroxaban?

Exclusivity rights for brand-name Rivaroxaban expired in 2024.

Sources:

[1] DrugPatentWatch.com (drugpatentwatch.com)

[2] DrugPatentWatch.com